RBC raises target for Illumina stock to USD 310
Published on 10/05/2026 at 15:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Illumina stock (ISIN US4523271090) was trading at EUR 243.68 at Lang & Schwarz on October 5, 2026 at 3:02 p.m. CEST, up 0.42 percent from the EUR 242.65 prior close. According to Stock Analysis on October 5, 2026, RBC Capital maintained its Buy rating and raised its price target from USD 230.00 to USD 310.00.
RBC target reaches USD 310
The RBC action is the latest major analyst update listed for Illumina. The new USD 310.00 target is USD 36.96 above the October 2 Nasdaq close of USD 273.04, while the Lang & Schwarz quote provides the euro reference for German investors.
MarketBeat lists 18 analyst ratings, including 10 Buys, 6 Holds and 2 Sells. Its average target is USD 214.69, which is 21.37 percent below the USD 273.04 Nasdaq close on October 2, 2026, showing the gap between the newest bullish target and the broader consensus.
Second-quarter growth supports the case
Illumina reported USD 1.16 billion in revenue and USD 207.0 million in earnings for the second quarter of 2026, according to Yahoo Finance. The same quarter carried earnings per share of USD 1.31 against a USD 1.23 estimate, while revenue was up 9.40 percent year over year, according to MarketBeat.
That combination gives the analyst debate a concrete operating anchor: the latest quarter delivered USD 0.08 more earnings per share than consensus, but the average target remains below the recent Nasdaq price. The company sells sequencing instruments, consumables and genomic analysis services, with applications spanning research, diagnostics and precision health.
Stock remains near its yearly high
On the Nasdaq, Illumina closed at USD 273.04 on October 2, 2026, against a 52-week range of USD 88.00 to USD 280.17. Its market capitalization was USD 41.3 billion on October 2, 2026, and the stock was 2.54 percent below its 52-week high based on those Nasdaq values.
At Lang & Schwarz, the intraday price was EUR 243.68 on October 5, 2026 at 3:02 p.m. CEST, plus 0.42 percent versus the Lang & Schwarz prior close of EUR 242.65. The further course of trading is shown by the continuously updated real-time quote of Illumina stock.
Illumina stock facts
- Company: Illumina, Inc.
- ISIN: US4523271090
- Ticker: ILMN
- Primary exchange: Nasdaq
- Price Lang & Schwarz as of October 5, 2026, 3:02 p.m. CEST: EUR 243.68
- Change versus prior close: plus 0.42 percent
- Prior close Lang & Schwarz October 2, 2026: EUR 242.65
- Market capitalization: USD 41.3 billion as of October 2, 2026
- 52-week range: USD 88.00-280.17 as of October 2, 2026
- Sector / Industry: Healthcare / Diagnostics and Research
- Index membership: S&P 500
